Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Cardiff Oncology (CRDF) Other Gross PP&E Adjustments (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 6.01% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, up 6.01% year-over-year, with the annual reading at $2.8 million for FY2025, 6.01% up from the prior year.
  • Other Gross PP&E Adjustments hit $2.8 million in Q4 2025 for Cardiff Oncology, up from -$764000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $4.2 million in Q2 2025 to a low of -$764000.0 in Q3 2025.
  • Historically, Other Gross PP&E Adjustments has averaged $2.4 million across 5 years, with a median of $2.7 million in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 1613.85% in 2022 and later crashed 120.4% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $65000.0 in 2021, then soared by 1613.85% to $1.1 million in 2022, then soared by 68.31% to $1.9 million in 2023, then skyrocketed by 39.41% to $2.6 million in 2024, then increased by 6.01% to $2.8 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for CRDF at $2.8 million in Q4 2025, -$764000.0 in Q3 2025, and $4.2 million in Q2 2025.